Association between monovalent influenza A (H1N1) pdm09 vaccine and pneumonia among the elderly in the 2009-2010 season in Japan: A case-control study. 2015

Kyoko Kondo, and Kanzo Suzuki, and Masakazu Washio, and Satoko Ohfuji, and Wakaba Fukushima, and Akiko Maeda, and Yoshio Hirota, and
a Department of Public Health; Faculty of Medicine; Osaka City University ; Osaka , Japan.

We investigated the association between monovalent influenza A (H1N1) pdm09 (H1N1pdm) vaccine and pneumonia in elderly people. Study design was a hospital-based, matched case-control study. Cases comprised patients ≥ 65 years old who had been newly diagnosed with pneumonia. For each case, 2 controls were defined as individuals with other diseases (not pneumonia) who were matched by sex, age, entry date, and the visited hospital. Study period was the interval from 1 September 2009 until 30 September 2010. Because a pandemic of influenza A (H1N1) occurred during study period, we analyzed selected subjects who had enrolled during the influenza A (H1N1) pandemic. We calculated the odds ratios (ORs) and 95% confidence intervals (CIs) for pneumonia in H1N1pdm-vaccinated subjects compared with unvaccinated subjects using a conditional logistic regression model to assess the association between H1N1pdm vaccine and pneumonia. The subjects during the period of the influenza A (H1N1) pandemic were 20 cases and 40 controls. Subjects who had received H1N1pdm vaccine showed a significantly decreased OR for pneumonia (OR = 0.10, 95% CI = 0.01-0.98) compared with unvaccinated subjects. In conclusion, H1N1pdm vaccination may have prevented pneumonia among the elderly during the 2009-2010 influenza A (H1N1) pandemic in Japan.

UI MeSH Term Description Entries
D007251 Influenza, Human An acute viral infection in humans involving the respiratory tract. It is marked by inflammation of the NASAL MUCOSA; the PHARYNX; and conjunctiva, and by headache and severe, often generalized, myalgia. Grippe,Human Flu,Human Influenza,Influenza in Humans,Influenza,Flu, Human,Human Influenzas,Influenza in Human,Influenzas,Influenzas, Human
D007252 Influenza Vaccines Vaccines used to prevent infection by viruses in the family ORTHOMYXOVIRIDAE. It includes both killed and attenuated vaccines. The composition of the vaccines is changed each year in response to antigenic shifts and changes in prevalence of influenza virus strains. The flu vaccines may be mono- or multi-valent, which contains one or more ALPHAINFLUENZAVIRUS and BETAINFLUENZAVIRUS strains. Flu Vaccine,Influenzavirus Vaccine,Monovalent Influenza Vaccine,Universal Flu Vaccine,Universal Influenza Vaccine,Flu Vaccines,High-Dose Trivalent Influenza Vaccine,Influenza Vaccine,Influenza Virus Vaccine,Influenza Virus Vaccines,Influenzavirus Vaccines,Intranasal Live-Attenuated Influenza Vaccine,LAIV Vaccine,Monovalent Influenza Vaccines,Quadrivalent Influenza Vaccine,Trivalent Influenza Vaccine,Trivalent Live Attenuated Influenza Vaccine,Universal Flu Vaccines,Universal Influenza Vaccines,Flu Vaccine, Universal,High Dose Trivalent Influenza Vaccine,Influenza Vaccine, Monovalent,Influenza Vaccine, Quadrivalent,Influenza Vaccine, Trivalent,Influenza Vaccine, Universal,Intranasal Live Attenuated Influenza Vaccine,Vaccine, Flu,Vaccine, Influenza,Vaccine, Influenza Virus,Vaccine, Influenzavirus,Vaccine, LAIV,Vaccine, Monovalent Influenza,Vaccine, Quadrivalent Influenza,Vaccine, Trivalent Influenza,Virus Vaccine, Influenza
D007564 Japan A country in eastern Asia, island chain between the North Pacific Ocean and the Sea of Japan, east of the Korean Peninsula. The capital is Tokyo. Bonin Islands
D008297 Male Males
D011014 Pneumonia Infection of the lung often accompanied by inflammation. Experimental Lung Inflammation,Lobar Pneumonia,Lung Inflammation,Pneumonia, Lobar,Pneumonitis,Pulmonary Inflammation,Experimental Lung Inflammations,Inflammation, Experimental Lung,Inflammation, Lung,Inflammation, Pulmonary,Inflammations, Lung,Inflammations, Pulmonary,Lobar Pneumonias,Lung Inflammation, Experimental,Lung Inflammations,Lung Inflammations, Experimental,Pneumonias,Pneumonias, Lobar,Pneumonitides,Pulmonary Inflammations
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000369 Aged, 80 and over Persons 80 years of age and older. Oldest Old
D016022 Case-Control Studies Comparisons that start with the identification of persons with the disease or outcome of interest and a control (comparison, referent) group without the disease or outcome of interest. The relationship of an attribute is examined by comparing both groups with regard to the frequency or levels of outcome over time. Case-Base Studies,Case-Comparison Studies,Case-Referent Studies,Matched Case-Control Studies,Nested Case-Control Studies,Case Control Studies,Case-Compeer Studies,Case-Referrent Studies,Case Base Studies,Case Comparison Studies,Case Control Study,Case Referent Studies,Case Referrent Studies,Case-Comparison Study,Case-Control Studies, Matched,Case-Control Studies, Nested,Case-Control Study,Case-Control Study, Matched,Case-Control Study, Nested,Case-Referent Study,Case-Referrent Study,Matched Case Control Studies,Matched Case-Control Study,Nested Case Control Studies,Nested Case-Control Study,Studies, Case Control,Studies, Case-Base,Studies, Case-Comparison,Studies, Case-Compeer,Studies, Case-Control,Studies, Case-Referent,Studies, Case-Referrent,Studies, Matched Case-Control,Studies, Nested Case-Control,Study, Case Control,Study, Case-Comparison,Study, Case-Control,Study, Case-Referent,Study, Case-Referrent,Study, Matched Case-Control,Study, Nested Case-Control

Related Publications

Kyoko Kondo, and Kanzo Suzuki, and Masakazu Washio, and Satoko Ohfuji, and Wakaba Fukushima, and Akiko Maeda, and Yoshio Hirota, and
August 2011, Vaccine,
Kyoko Kondo, and Kanzo Suzuki, and Masakazu Washio, and Satoko Ohfuji, and Wakaba Fukushima, and Akiko Maeda, and Yoshio Hirota, and
April 2013, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin,
Kyoko Kondo, and Kanzo Suzuki, and Masakazu Washio, and Satoko Ohfuji, and Wakaba Fukushima, and Akiko Maeda, and Yoshio Hirota, and
November 2016, Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases,
Kyoko Kondo, and Kanzo Suzuki, and Masakazu Washio, and Satoko Ohfuji, and Wakaba Fukushima, and Akiko Maeda, and Yoshio Hirota, and
January 2015, Journal of public health management and practice : JPHMP,
Kyoko Kondo, and Kanzo Suzuki, and Masakazu Washio, and Satoko Ohfuji, and Wakaba Fukushima, and Akiko Maeda, and Yoshio Hirota, and
May 2012, Emerging infectious diseases,
Kyoko Kondo, and Kanzo Suzuki, and Masakazu Washio, and Satoko Ohfuji, and Wakaba Fukushima, and Akiko Maeda, and Yoshio Hirota, and
September 2013, Vaccine,
Kyoko Kondo, and Kanzo Suzuki, and Masakazu Washio, and Satoko Ohfuji, and Wakaba Fukushima, and Akiko Maeda, and Yoshio Hirota, and
December 2011, American journal of preventive medicine,
Kyoko Kondo, and Kanzo Suzuki, and Masakazu Washio, and Satoko Ohfuji, and Wakaba Fukushima, and Akiko Maeda, and Yoshio Hirota, and
November 2016, Revista do Instituto de Medicina Tropical de Sao Paulo,
Kyoko Kondo, and Kanzo Suzuki, and Masakazu Washio, and Satoko Ohfuji, and Wakaba Fukushima, and Akiko Maeda, and Yoshio Hirota, and
December 2009, The New England journal of medicine,
Kyoko Kondo, and Kanzo Suzuki, and Masakazu Washio, and Satoko Ohfuji, and Wakaba Fukushima, and Akiko Maeda, and Yoshio Hirota, and
January 2012, MMWR. Morbidity and mortality weekly report,
Copied contents to your clipboard!